Wolbachia disrupts eukaryotic endolysosomal membrane dynamics
沃尔巴克氏菌破坏真核细胞内溶酶体膜动力学
基本信息
- 批准号:10667824
- 负责人:
- 金额:$ 18.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-15 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAntibioticsBacteriaBacterial ProteinsBindingBiochemicalBiological ModelsBiologyBiotinylationBrugiaBrugia malayiCellular biologyCessation of lifeComplexCoupledDataDevelopmentDiseaseDissectionElephantiasisEndosomesEnsureEukaryotaFamilyFilarial ElephantiasesFilariasisGenesGeneticGoalsHumanIn VitroIndividualIntracellular MembranesIvermectinKnowledgeLaboratoriesLipid BiochemistryMembraneMembrane FusionMembrane ProteinsMicrobiologyModelingMolecularNematodaOcular OnchocerciasisOrganismOutcomePathogenicityPathway interactionsPhysiologyPopulationProcessProteinsPublishingReagentRegulationReportingReproductionResistanceSaccharomycetalesSymbiosisSystemTechnologyTestingTissuesVacuoleWolbachiaWorkYeastsendosymbiontgenetic manipulationglobal healthhuman diseasehuman pathogenin vivoinhibitorinsightnovelpathogenprotein degradationprotein functionprotein protein interactionprotein transportreceptortooltraffickingyeast protein
项目摘要
PROJECT SUMMARY
Filarial nematodes of the family Onchocercidae cause debilitating human diseases, such as lymphatic
filariasis. As approximately 150 million individuals are currently infected with these nematodes, obtaining in-
depth knowledge of pathogen biology will serve to address a global health issue. It is known that the filarial
nematode, Brugia malayi, harbors an intracellular endosymbiotic bacterium of the Wolbachia genus, and this
relationship is essential; clearance of Wolbachia from the nematode with antibiotics leads to eventual nematode
death. Understanding the mechanisms by which Wolbachia maintains its intracellular survival within nematodes
would therefore likely provide an important avenue towards controlling pathogenic nematode populations, but
both Brugia and Wolbachia are not amenable to genetic manipulations. Discoveries of important
bacterium:nematode interactions at the molecular level, therefore, have proven exceedingly difficult.
In this proposal, our goals are to utilize proteins from Wolbachia to genetically and biochemically dissect
conserved pathways of endolysosomal membrane dynamics in yeast. These secreted “effector” proteins are
known to alter host processes in order to support the survival of the bacterium in the eukaryotic host and to
ensure its own reproduction, and are therefore potent reagents that impact eukaryotic physiology. To this end,
my laboratory has employed the budding yeast, Saccharomoyces cerevisiae (Sce), as a model system towards
the discovery of bacterial proteins that modulate eukaryotic cellular biology, with a focus on those proteins which
inhibit intracellular membrane fusion and protein trafficking pathways.
In a previous screen of candidate wBm secreted effector proteins, we have already identified proteins
from wBm that have the ability to manipulate eukaryotic biology. In this work, we show that one such protein,
wBm0152, strongly inhibits endosome:vacuole trafficking pathways in vitro. This inhibition appears to result from
modulation of the conserved ESCRT complex. As wBm is known to alter membrane dynamics in its host during
its symbiosis, and coupled with the fact that regulation of membrane dynamics is strongly conserved throughout
eukaryotes, the detailed genetic, molecular, and biochemical studies carried out in this proposal will be applicable
to wBm:B. malayi interactions, and thus, human filarial diseases. Finally, leveraging our laboratory's strengths
in microbiology, cellular biology, and protein/ lipid biochemistry, we will carefully detail the biochemical activity of
this Wolbachia-derived ESCRT modulator and identify important regulators and binding partners in yeast, which
are likely conserved in Brugia. This work will begin to describe heretofore unknown wBm:B. malayi interactions,
thus providing novel insight into not only Brugia physiology, but also provide new insight into ESCRT-dependent
activities in eukaryotes.
项目摘要
盘尾丝虫科(Onchocerediae)的丝状线虫引起使人衰弱的疾病,例如淋巴结炎。
丝虫病由于目前约有1.5亿人感染这些线虫,
病原体生物学的深入知识将有助于解决全球健康问题。众所周知,
线虫马来丝虫(Brugia malayi)具有沃尔巴克氏体属(Wolbachia genus)的细胞内共生细菌,并且该
这种关系是必不可少的;用抗生素清除线虫中的沃尔巴克氏体,
死亡了解沃尔巴克氏体在线虫体内维持细胞内存活的机制
因此可能为控制病原线虫种群提供重要途径,
布鲁吉亚氏菌和沃尔巴克氏菌都不适合基因操作。重要发现
因此,细菌与线虫在分子水平上的相互作用被证明是极其困难的。
在这项提议中,我们的目标是利用沃尔巴克氏体的蛋白质,
酵母内溶酶体膜动力学的保守途径。这些分泌的“效应”蛋白是
已知改变宿主过程以支持细菌在真核宿主中的存活,
确保其自身繁殖,因此是影响真核生物生理学的有效试剂。为此目的,
我的实验室采用了芽殖酵母,酿酒酵母(Sce),作为一个模型系统,
发现调节真核细胞生物学的细菌蛋白质,重点是那些
抑制细胞内膜融合和蛋白运输途径。
在先前的候选wBm分泌效应蛋白的筛选中,我们已经鉴定了
有能力操纵真核生物的wBM。在这项工作中,我们发现了一种这样的蛋白质,
wBm 0152,强烈抑制内体:空泡运输途径在体外。这种抑制似乎是由
调节保守的ESCRT复合物。由于已知wBm在其宿主中改变膜动力学,
它的共生,再加上事实上,膜动力学的调节是强烈保守的整个
真核生物,本提案中进行的详细遗传、分子和生物化学研究将适用于
到wBM:B。马来人之间的相互作用,从而导致人类丝虫病。最后,利用我们实验室的优势
在微生物学、细胞生物学和蛋白质/脂质生物化学中,我们将仔细地详细介绍
这种沃尔巴克氏体衍生的ESCRT调节剂,并确定了酵母中的重要调节剂和结合伴侣,
很可能是布鲁吉亚的保守基因这项工作将开始描述迄今未知的wBM:B。马来互动,
从而不仅为布鲁日丝虫生理学提供了新的见解,而且为ESCRT依赖性
真核生物的活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vincent Joseph Starai其他文献
Vincent Joseph Starai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vincent Joseph Starai', 18)}}的其他基金
Bacterial inhibitors of eukaryotic membrane fusion
真核细胞膜融合的细菌抑制剂
- 批准号:
9187910 - 财政年份:2013
- 资助金额:
$ 18.42万 - 项目类别:
Bacterial inhibitors of eukaryotic membrane fusion
真核细胞膜融合的细菌抑制剂
- 批准号:
8600238 - 财政年份:2013
- 资助金额:
$ 18.42万 - 项目类别:
Bacterial inhibitors of eukaryotic membrane fusion
真核细胞膜融合的细菌抑制剂
- 批准号:
8502876 - 财政年份:2013
- 资助金额:
$ 18.42万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 18.42万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 18.42万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 18.42万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 18.42万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 18.42万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 18.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)